MX2018003802A - Formulacion de hipericina para el diagnostico fotodinamico. - Google Patents

Formulacion de hipericina para el diagnostico fotodinamico.

Info

Publication number
MX2018003802A
MX2018003802A MX2018003802A MX2018003802A MX2018003802A MX 2018003802 A MX2018003802 A MX 2018003802A MX 2018003802 A MX2018003802 A MX 2018003802A MX 2018003802 A MX2018003802 A MX 2018003802A MX 2018003802 A MX2018003802 A MX 2018003802A
Authority
MX
Mexico
Prior art keywords
formulation
hypericin
photodynamic diagnosis
polyvinylpyrrolidone
cancer
Prior art date
Application number
MX2018003802A
Other languages
English (en)
Inventor
Welzig Stefan
Kälz Beate
Gungl József
Gerdes Klaus
Frantsits Werner
Abrahamsberg Christina
Original Assignee
Sanochemia Pharmazeutika Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanochemia Pharmazeutika Ag filed Critical Sanochemia Pharmazeutika Ag
Publication of MX2018003802A publication Critical patent/MX2018003802A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/121—Ketones acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0071—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form solution, solute
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00—Quinones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00—Quinones
    • C07C50/26—Quinones containing groups having oxygen atoms singly bound to carbon atoms
    • C07C50/36—Quinones containing groups having oxygen atoms singly bound to carbon atoms the quinoid structure being part of a condensed ring system having four or more rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Una formulación que se puede usar como un fotosensibilizador en la detección temprana de cáncer, por ejemplo, cáncer de vejiga, que contiene enlace polivinilo pirrolidona o sal de sodio de hipercina de pirrolidona-complejante.
MX2018003802A 2015-09-28 2016-04-07 Formulacion de hipericina para el diagnostico fotodinamico. MX2018003802A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT6292015 2015-09-28
PCT/AT2016/000034 WO2017054018A1 (de) 2015-09-28 2016-04-07 Formulierung von hypericin zur photodynamischen diagnose

Publications (1)

Publication Number Publication Date
MX2018003802A true MX2018003802A (es) 2019-06-24

Family

ID=55854523

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018003802A MX2018003802A (es) 2015-09-28 2016-04-07 Formulacion de hipericina para el diagnostico fotodinamico.

Country Status (14)

Country Link
US (2) US9629932B2 (es)
EP (1) EP3237019B1 (es)
JP (1) JP6800232B2 (es)
KR (1) KR20180080210A (es)
CN (1) CN108289967A (es)
AU (1) AU2016330390B2 (es)
BR (1) BR112018006066A2 (es)
CA (1) CA3000419C (es)
DK (1) DK3237019T3 (es)
ES (1) ES2762902T3 (es)
MX (1) MX2018003802A (es)
PL (1) PL3237019T3 (es)
RU (1) RU2018114868A (es)
WO (1) WO2017054018A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108715693B (zh) * 2018-06-29 2020-08-25 南方科技大学 一种光化学除去氧气来保护光敏剂的三重激发态的介质以及方法和应用
EP3593815A1 (de) 2018-07-13 2020-01-15 Planta Naturstoffe Vertriebsges.m.b.h. Hypericin-pvp komplex mit hohem hypericinanteil
WO2022100750A1 (zh) * 2020-11-16 2022-05-19 北京厚燊维康科技有限责任公司 可用于光动力治疗或诊断的制剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19814014A1 (de) 1997-12-19 1999-09-30 Krewel Meuselbach Gmbh Arzneipflanzentrockenextrakte
DE19756677A1 (de) 1997-12-19 1999-06-24 Krewel Meuselbach Gmbh Arzneipflanzentrockenextrakte
EP1040825A1 (en) * 1999-03-11 2000-10-04 K.U. Leuven Research & Development Means for diagnosing bladder carcinoma
AT408835B8 (de) 2000-05-23 2002-07-25 Andreas Dipl Ing Dr Kubin Präparation von hypericin gebunden an polyvinylpyrrolidon (pvp) verschiedenen polymerisations- und vernetzungsgrades
CN102525937B (zh) * 2012-01-21 2013-07-17 中国农业科学院兰州畜牧与兽药研究所 一种金丝桃素白蛋白纳米粒的制备方法
DE102014204138A1 (de) 2014-03-06 2015-09-24 Briu Gmbh Pharmazeutische Formulierung, Verfahren zur Herstellung der pharmazeutischen Formulierung und Infusionslösung sowie deren Verwendung als Medizinprodukt und/oder als Medikament
US10143751B2 (en) * 2015-09-28 2018-12-04 Sanochemia Pharmazeutika Ag Photodynamic therapy, formulation usable for this purpose, and method for the production and use thereof

Also Published As

Publication number Publication date
AU2016330390B2 (en) 2019-05-02
CA3000419A1 (en) 2017-04-06
AU2016330390A1 (en) 2018-05-10
JP6800232B2 (ja) 2020-12-16
DK3237019T3 (da) 2020-01-13
US9629932B2 (en) 2017-04-25
US9775900B2 (en) 2017-10-03
US20170087256A1 (en) 2017-03-30
ES2762902T3 (es) 2020-05-26
EP3237019A1 (de) 2017-11-01
RU2018114868A (ru) 2019-10-28
PL3237019T3 (pl) 2020-04-30
CN108289967A (zh) 2018-07-17
US20170196976A1 (en) 2017-07-13
JP2018534349A (ja) 2018-11-22
RU2018114868A3 (es) 2019-10-28
CA3000419C (en) 2021-03-16
WO2017054018A1 (de) 2017-04-06
BR112018006066A2 (pt) 2018-10-09
EP3237019B1 (de) 2019-10-09
KR20180080210A (ko) 2018-07-11

Similar Documents

Publication Publication Date Title
IL252796A0 (en) Therapeutic, diagnostic and prognostic methods for bladder cancer
EP4324473A3 (en) Multiparametric nucleic acid optimization
ECSP17015977A (es) Terapia de combinacion
MX2015017201A (es) Derivados de pirazolopiridina para uso en el tratamiento del cancer de vejiga.
EA201400178A1 (ru) Лечение рака молочной железы
EP3207162A4 (en) Combination therapy for use in cancer therapy
EP3157337A4 (en) Induced photodynamic therapy using nanoparticle scintillators as transducers
BR112018005409A2 (pt) terapêutica de glicodirecionamento.
EA201792612A1 (ru) 6-аминохинолин-3-карбонитрилы в качестве модуляторов cot
IL256139B (en) Bladder cancer diagnosis methods
EP3180000A4 (en) Cancer diagnosis and therapy
CL2016001349A1 (es) Uso de derivados de bencimidazol-prolina
EP3209641A4 (en) Benzenesulfonamido and related compounds for use as agonists of ror and the treatement of disease
PH12016501769A1 (en) Treatment of intrahepatic cholestatic diseases
EP3541818A4 (en) PHOTOSENSITIZER
PH12017501071A1 (en) Dihydropyrimidin-2-one compounds and medical use thereof
EP3236478A4 (en) Working neutron source
EA201790687A1 (ru) Хинолинкарбоксамиды для применения в лечении множественной миеломы
EP3189333A4 (en) Diagnosis of cancer
MX2018005987A (es) Compuestos heterociclicos para el tratamiento de enfermedades.
MX2018003802A (es) Formulacion de hipericina para el diagnostico fotodinamico.
BR112018012116A2 (pt) terapia intravesical para câncer de bexiga
MX2018003801A (es) Formulacion de hipericina para la terapia fotodinamica.
EP3273974A4 (en) Therapy for malignant disease
WO2015013233A3 (en) Methods and compositions for the treatment and diagnosis of bladder cancer